Reach More Patients Faster

Real-World Evidence. Captured at the Source.

Climedo is the leading eCOA and EDC platform for real-world and late-phase studies, powered by Autonomous Data Capture (ADC). Study data flows in with near-zero manual entry, so you get real-time insights on efficacy and safety while the study is still running.

2M+ Patients

EU-Based & GDPR-First

Developed with Clinicians

The ADC Advantage: From Source to EDC, Without Re-Typing

Autonomous Data Capture flows source data into your EDC in three stages, with near-zero manual entry: less typing for sites, fewer queries and more time for patients.

  1. Stage 1

    Source Capture

    Data originates without manual entry.

    • EHR and HIS integration
    • PDF upload and scan
    • Voice entry
    • Photo capture via smartphone
  2. Stage 2

    AI Extraction

    AI structures the unstructured.

    • Data mapping
    • Confidence score
    • 4 eye principle
    • Unit conversion
    • Any-language input
  3. Stage 3

    Filled eCRF

    Human-approved import, with the groundwork done by AI.

    • GCP-compliant
    • Full audit trail
    • 21 CFR Part 11
Discharge summary CARDIOLOGY · UNIVERSITY HOSPITAL
04.09.2026
SUBJECT004-017 BORN1961 VISIT2 PAGE1 / 4

DIAGNOSIS

Type 2 diabetes mellitus, ICD-10 E11.9

MEDICATION ON DISCHARGE

Metformin1000 mg BID
Ramipril5 mg QD
Atorvastatin20 mg QD

LABORATORY

HbA1c7.2 %
Creatinine0.9 mg/dL
LDL cholesterol128 mg/dL

VITAL SIGNS

Blood pressure138 / 86 mmHg
Heart rate74 bpm
PD DR. MED. A. KELLER
SIGNED
04.09.2026
DXE11.9 · Type 2 diabetes
LABHbA1c 7.2 %
CONMEDMetformin 1000 mg
VITAL138 / 86 mmHg
Smart Import
Source document
AUTOMATED UNIT CONVERSION
LDL128 mg/dL→3.31 mmol/L
Creatinine0.9 mg/dL→79.6 µmol/L
Every value read in place, next to its source.
Result: near-zero manual data entry. Less site burden, faster study timelines, better data quality.

Launch in Days, Not Months

3 to 5 days to launch, versus 2 to 3 weeks with legacy EDC.

Protocol-to-Study: the AI Study Configurator visualizes your protocol, turns it into study specs and generates the study, from eCRFs, visits, randomization and ePRO to edit checks, queries and SAE forms, with your team approving each step. What traditionally takes weeks now takes days, from protocol upload to live study.

Industries

Built for Your Kind of Research

%

Customer Recommendation

~

Sites

+

Projects

Climedo Users

M+

Patients

%+

Patient Adherence

Fast AI-native study setupReal-time data captureand visualisation Hybrid Trials eConsent &Televisits

Clinical Trials and Surveys

Our Solutions for Your Clinical Data Capture

Capture study data straight from the source with Autonomous Data Capture (ADC), plus EDC, eCRF, ePRO and eSurveys, for real-world evidence with near-zero manual entry.

More About the Climedo Platform

From Data to Dialogue

Instead of a static report years after study kick-off, Climedo turns eCOA & ePRO data into interactive dashboards while the study is still running. Medical Science Liaison Managers and HCPs filter by subpopulation in real time and see anonymized, aggregated results for that patient group, a basis for scientific dialogue instead of a one-way report.

Benchmarking

Compare an individual patient against the study population. Select the patient, filter by parameters such as body weight or BMI, and see where they sit in the histogram for a given visit, so treatment duration stays comparable.

Progression

Follow a patient’s selected parameter across site visits and detect outliers or changes in medical parameters at an early stage. Descriptive while the study runs, never a prescribing aid.

EU-Based & GDPR-First

Data Hosting That Meets Your Compliance Needs.

All servers are in Frankfurt (AWS region): for EU studies, no data is processed outside the EU; US hosting is possible on request. Your study data sits with an ISO 27001-certified hosting partner, with strong data separation and state-of-the-art encryption, reviewed at federal level by the BSI and the BfDI. The Climedo system is audited against ICH GCP, GAMP5 and FDA 21 CFR Part 11, so sponsors in the EU and the US can run studies on one platform without a compliance workaround.

Germany
Successful Data Capture for a Phase IV Study with ePRO solutions

Successful Data Capture for a Phase IV Study With ePRO Solutions

Read Case Study

Digital Health Bites

Go to our Blog Arrow Right Mini